French Regulator Shutters Vaccine Manufacturer Over GMP Deficiencies

By Sam | April 11, 2016

France’s National Agency for Medicines and Health Products Safety has ordered French vaccine maker Theravectys to halt production at its Villejuif plant for seven months after apparently finding numerous GMP deficiencies.
Source: Drug GMP Report

Posted in Drug GMP Report